☆ 4.6 Article

Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID-19: Multicentre observational study in the UK

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

Tracy Y. Wang et al.

Summary: This study aimed to determine whether anticoagulation is effective in reducing death and thromboembolic complications among patients discharged after COVID-19 hospitalization. The study was terminated early due to a lower-than-expected event rate and declining COVID-19 hospitalizations, leading to inconclusive results.

ANNALS OF INTERNAL MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19

Lan Shen et al.

Summary: The study found that the use of LMWH in hospitalized COVID-19 patients was associated with lower all-cause in-hospital mortality compared to non-LMWH users, especially among more severely ill patients.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Add to Collection

Article Medicine, General & Internal

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti et al.

Summary: This study investigated the efficacy of rivaroxaban thromboprophylaxis for 35 days in patients discharged after hospitalisation due to COVID-19. The results showed that this treatment significantly reduced the incidence of venous thromboembolism, with no major bleeding events reported.

LANCET (2022)

Add to Collection

Letter Hematology

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis

Marco Zuin et al.

THROMBOSIS RESEARCH (2022)

Add to Collection

Review Pharmacology & Pharmacy

Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports

Konstantinos G. Kyriakoulis et al.

Summary: This study conducted a systematic review to analyze national and international guidelines on thromboprophylaxis strategies in COVID-19 patients. The key to thromboprophylaxis strategies lies in stratifying thrombotic and bleeding risks. The majority of guidelines recommend prophylactic dose of low molecular weight heparin for all hospitalized patients.

CURRENT VASCULAR PHARMACOLOGY (2022)

Add to Collection

Article Hematology

ISTH guidelines for antithrombotic treatment in COVID-19

Sam Schulman et al.

Summary: Antithrombotic agents, particularly heparins, are recommended for patients with COVID-19 to reduce thromboembolism risk. The optimal dosing and timing of these treatments, as well as the benefits of other antithrombotic agents, are still unclear. A panel of experts developed 12 recommendations based on high- to moderate-quality evidence, including the use of prophylactic or therapeutic dose heparin for different patient groups. Additional weak recommendations were made for the use of sulodexide, adding antiplatelet agents, and prophylactic rivaroxaban in select patients. Future updates will incorporate new evidence and may modify these recommendations.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Review Hematology

Mechanisms of thrombosis and cardiovascular complications in COVID-19

Eden M. Page et al.

Summary: COVID-19 disease is characterized by interactions between hyperactive coagulation and complement systems, resulting in a pro-thrombotic state and tissue injury. D-dimer is the most significant prognostic marker of disease severity, with the presence of thrombocytopenia being a key indicator of patient deterioration. Further research is needed to understand the underlying pathophysiology in COVID-19 and the potential implications for disease progression and patient management.

THROMBOSIS RESEARCH (2021)

Add to Collection

Article Hematology

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Dimitrios Giannis et al.

Summary: Thromboembolic events and mortality from subclinical thrombotic events frequently occur in COVID-19 inpatients. Postdischarge VTE, ATE, and ACM are common, with advanced age and cardiovascular risk factors increasing the risk. Postdischarge anticoagulation can significantly reduce the risk by 46%.

BLOOD (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Patrick R. Lawler et al.

Summary: This study showed that therapeutic-dose anticoagulation with heparin in non-critically ill patients with Covid-19 increased the likelihood of survival to hospital discharge and reduced the need for cardiovascular or respiratory organ support compared to usual-care thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Hematology

Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality

Fien A. von Meijenfeldt et al.

Summary: The study found that COVID-19 patients with higher levels of respiratory support have significantly increased in vivo activation of coagulation and fibrinolysis, despite receiving anticoagulant therapy. Blood markers such as fibrinogen, von Willebrand factor, etc., also change with increasing levels of respiratory support.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Review Medicine, General & Internal

Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials

Yazan Zayed et al.

INTERNAL MEDICINE JOURNAL (2020)

Add to Collection

Review Physiology

Heparin as a therapy for COVID-19: current evidence and future possibilities

Joseph A. Hippensteel et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Add to Collection

Article Hematology

Postdischarge venous thromboembolism following hospital admission with COVID-19

Lara N. Roberts et al.

BLOOD (2020)

Add to Collection

Editorial Material Hematology

Coagulation abnormalities and thrombosis in patients with COVID-19

Marcel Levi et al.

LANCET HAEMATOLOGY (2020)

Add to Collection

Review Hematology

Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A US Perspective

Alex C. Spyropoulos et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Review Hematology

Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis

Kochawan Boonyawat et al.

THROMBOSIS JOURNAL (2020)

Add to Collection

Review Medicine, General & Internal

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Mahmoud B. Malas et al.

ECLINICALMEDICINE (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Preventing hospital associated venous thromboembolism

Beverley J. Hunt

BMJ-BRITISH MEDICAL JOURNAL (2019)

Add to Collection

Article Hematology

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

S. Kaatz et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Add to Collection

Article Medicine, General & Internal

Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients

Alpesh N. Amin et al.

JOURNAL OF HOSPITAL MEDICINE (2012)

Add to Collection

Article Critical Care Medicine

Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE

Alex C. Spyropoulos et al.

CHEST (2011)

Add to Collection

Article Hematology

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

S Schulman et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.